40 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Pfizer (PFE) Gets EU Nod for Expanded Use of Pneumococcal Jab https://www.zacks.com/stock/news/2240861/pfizer-pfe-gets-eu-nod-for-expanded-use-of-pneumococcal-jab?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240861 Mar 14, 2024 - Following the label expansion, Pfizer's (PFE) 20-valent pneumococcal conjugate vaccine is authorized for use in individuals aged six weeks and older.
Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know https://www.zacks.com/stock/news/2234897/merck-mrk-stock-falls-amid-market-uptick-what-investors-need-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2234897 Mar 01, 2024 - In the most recent trading session, Merck (MRK) closed at $126.96, indicating a -0.15% shift from the previous trading day.
Top Research Reports for Merck, ServiceNow & Blackstone https://www.zacks.com/commentary/2228528/top-research-reports-for-merck-servicenow-blackstone?cid=CS-ZC-FT-research_daily-2228528 Feb 20, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), ServiceNow, Inc. (NOW) and Blackstone Inc. (BX).
Moderna (MRNA) Gears Up for Q4 Earnings: Will It Top Estimates? https://www.zacks.com/stock/news/2228028/moderna-mrna-gears-up-for-q4-earnings-will-it-top-estimates?cid=CS-ZC-FT-analyst_blog|earnings_preview-2228028 Feb 19, 2024 - Investors' focus will likely be on updates on Moderna's (MRNA) pipeline, especially its late-stage pipeline candidates, when it reports fourth-quarter earnings.
Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow https://www.zacks.com/stock/news/2227548/corcept-cort-q4-earnings-beat-estimates-korlym-sales-grow?cid=CS-ZC-FT-analyst_blog|earnings_article-2227548 Feb 16, 2024 - Corcept (CORT) beats on both earnings and sales in the fourth quarter. The company also reiterates its previously provided guidance for 2024.
Pharma Stock Roundup: AZN & LLY's Q4 Earnings, NVO, NVS & MRK's M&A Deals https://www.zacks.com/stock/news/2224190/pharma-stock-roundup-azn-lly-s-q4-earnings-nvo-nvs-mrk-s-m-a-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2224190 Feb 09, 2024 - Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements.
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month https://www.fool.com/investing/2024/02/08/heres-why-merck-eli-lilly-and-novo-nordisk-stocks/?source=iedfolrf0000001 Feb 08, 2024 - Investors are still excited about obesity treatments and weight-management drugs.
Merck (MRK) Unit to Buy Elanco's Aqua Business for $1.3B https://www.zacks.com/stock/news/2221915/merck-mrk-unit-to-buy-elanco-s-aqua-business-for-1-3b?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221915 Feb 06, 2024 - Merck's (MRK) Animal Health unit is set to strengthen its position with the acquisition of Elanco Animal Health's aqua business for $1.3 billion. The transaction is expected to close by mid-2024.
Stock Market News for Feb 2, 2024 https://www.zacks.com/stock/news/2220267/stock-market-news-for-feb-2-2024?cid=CS-ZC-FT-market_news-2220267 Feb 02, 2024 - U.S. stocks closed higher on Thursday as they tried to recover from a massive selloff in the previous session after the Federal Reserve held interest rates steady but also said that a rate cut in March is unlikely.
Pharma Stock Roundup: PFE, MRK, NVO & SNY's Q4 Earnings, FDA Updates https://www.zacks.com/stock/news/2220214/pharma-stock-roundup-pfe-mrk-nvo-sny-s-q4-earnings-fda-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-2220214 Feb 02, 2024 - Pfizer (PFE), Merck (MRK), Novartis (NVS), Novo Nordisk (NVO) and Sanofi (SNY) announce fourth-quarter and full-year 2023 results.

Pages: 1234

Page 1>